Potent P2Y12 Inhibitor Monotherapy vs DAPT After PCI in Patients With and Without STEMI
Caio A.M. Tavares, Patrícia O. Guimarães, Marcelo Franken, José Mariani, Stefano Garzón Dias Lemos, Breno Oliveira Almeida, Eduardo B. Martins, Estêvão Lanna Figueiredo, Aloísio M. da Rocha, Alexandre Soares, Marcos Maynar-Mariño, Bruno Paolino, Mayler Olombrada Nunes de Santos, Paulo Caramori, Rodrigo M Joaquim, Edgar Freitas Quintella, André F Antonangelo, Alberto G.T. Fonseca, Marcos S. Silveira, Milena R. da Fonseca, Frederico Monfardini, Silvia R.L. Assis, Leonardo R. Costa, José Carlos Nicolau, Andrei C. Spósito, Renato D. Lopes, Yoshinobu Onuma, Marco Valgimigli, Dominick J. Angiolillo, Patrick W. Serruys, Otávio Berwanger, Raúl D. Santos, Fernando Bacal, Pedro A. Lemos
Topics & Concepts
MedicineConventional PCIPercutaneous coronary interventionCardiologyInternal medicineAspirinP2Y12Acute coronary syndromeClopidogrelMajor bleedingMyocardial infarctionCoronary stentingCardiovascular eventPlatelet aggregation inhibitorStentCoronary stentAntiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction ResearchCardiac Ischemia and Reperfusion